Pretreatments with a novel pure potassium channel blocker, Nifekalant, were effective in the electrical atrial defibrillation: a report of two cases

Cardiovasc Drugs Ther. 2002 Dec;16(6):551-2. doi: 10.1023/a:1022967221661.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrial Fibrillation / therapy*
  • Combined Modality Therapy
  • Defibrillators, Implantable*
  • Electric Countershock*
  • Female
  • Humans
  • Male
  • Potassium Channel Blockers / therapeutic use*
  • Pyrimidinones / therapeutic use*

Substances

  • Anti-Arrhythmia Agents
  • Potassium Channel Blockers
  • Pyrimidinones
  • nifekalant